Verve Therapeutics Inc - VERV - stock price prediction, stock price target, analyst ratings from 8 analysts

Verve Therapeutics Inc has a share price target of US$ 15, revenue growth forecast of 31.1%, and profit growth estimate of -15.2% for FY25, based on top 8 analyst calls.